Correlation of active contact location with weight gain after subthalamic nucleus deep brain stimulation: a case series.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
13 Sep 2021
Historique:
received: 02 04 2021
accepted: 01 09 2021
entrez: 14 9 2021
pubmed: 15 9 2021
medline: 16 10 2021
Statut: epublish

Résumé

Weight gain (WG) is a frequently reported side effect of subthalamic deep brain stimulation; however, the underlying mechanisms remain unclear. The active contact locations influence the clinical outcomes of subthalamic deep brain stimulation, but it is unclear whether WG is directly associated with the active contact locations. We aimed to determine whether WG is associated with the subthalamic deep brain stimulation active contact locations. We enrolled 14 patients with Parkinson's disease who underwent bilateral subthalamic deep brain stimulation between 2013 and 2019. Bodyweight and body mass index were measured before and one year following the surgery. The Lead-DBS Matlab toolbox was used to determine the active contact locations based on magnetic resonance imaging and computed tomography. We also created sweet spot maps for WG using voxel-wise statistics, based on volume of tissue activation and the WG of each patient. Fluorodeoxyglucose-positron emission tomography data were also acquired before and one year following surgery, and statistical parametric mapping was used to evaluate changes in brain metabolism. We examined which brain regions' metabolism fluctuation significantly correlated with increased body mass index scores and positron emission tomography data. One year after surgery, the body mass index increase was 2.03 kg/m Although the mechanisms underlying WG following subthalamic deep brain stimulation are possibly multifactorial, our findings suggest that dorsal stimulation outside of STN may lead to WG. The metabolic changes in limbic and associative cortical regions after STN-DBS may also be one of the mechanisms underlying WG. Further studies are warranted to confirm whether dorsal stimulation outside of STN changes the activities of these cortical regions.

Sections du résumé

BACKGROUND BACKGROUND
Weight gain (WG) is a frequently reported side effect of subthalamic deep brain stimulation; however, the underlying mechanisms remain unclear. The active contact locations influence the clinical outcomes of subthalamic deep brain stimulation, but it is unclear whether WG is directly associated with the active contact locations. We aimed to determine whether WG is associated with the subthalamic deep brain stimulation active contact locations.
METHODS METHODS
We enrolled 14 patients with Parkinson's disease who underwent bilateral subthalamic deep brain stimulation between 2013 and 2019. Bodyweight and body mass index were measured before and one year following the surgery. The Lead-DBS Matlab toolbox was used to determine the active contact locations based on magnetic resonance imaging and computed tomography. We also created sweet spot maps for WG using voxel-wise statistics, based on volume of tissue activation and the WG of each patient. Fluorodeoxyglucose-positron emission tomography data were also acquired before and one year following surgery, and statistical parametric mapping was used to evaluate changes in brain metabolism. We examined which brain regions' metabolism fluctuation significantly correlated with increased body mass index scores and positron emission tomography data.
RESULTS RESULTS
One year after surgery, the body mass index increase was 2.03 kg/m
CONCLUSIONS CONCLUSIONS
Although the mechanisms underlying WG following subthalamic deep brain stimulation are possibly multifactorial, our findings suggest that dorsal stimulation outside of STN may lead to WG. The metabolic changes in limbic and associative cortical regions after STN-DBS may also be one of the mechanisms underlying WG. Further studies are warranted to confirm whether dorsal stimulation outside of STN changes the activities of these cortical regions.

Identifiants

pubmed: 34517835
doi: 10.1186/s12883-021-02383-6
pii: 10.1186/s12883-021-02383-6
pmc: PMC8436541
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

351

Subventions

Organisme : Ministry of Health, Welfare, and Labour, Japan
ID : 20FC1049
Organisme : Ministry of Health, Welfare, and Labour, Japan
ID : 20FC1049

Informations de copyright

© 2021. The Author(s).

Références

Mov Disord. 2006 Nov;21(11):1941-6
pubmed: 16972268
Neurology. 2009 Nov 24;73(21):1746-51
pubmed: 19933975
Obesity (Silver Spring). 2010 Aug;18(8):1552-7
pubmed: 20168310
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Mov Disord. 2003 Nov;18(11):1337-40
pubmed: 14639677
R Soc Open Sci. 2018 Jul 18;5(7):171177
pubmed: 30109035
Brain Behav. 2011 Sep;1(1):12-8
pubmed: 22398977
Neuroimage. 2019 Jan 1;184:293-316
pubmed: 30179717
J Neurol Neurosurg Psychiatry. 2018 May;89(5):493-498
pubmed: 29353236
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Clin Physiol Funct Imaging. 2012 May;32(3):214-20
pubmed: 22487156
Obes Rev. 2012 Jan;13(1):43-56
pubmed: 21902800
J Neurol Neurosurg Psychiatry. 2009 May;80(5):484-8
pubmed: 19060023
Neurol Sci. 2017 Dec;38(12):2123-2129
pubmed: 28913772
Parkinsonism Relat Disord. 2009 Nov;15(9):709-11
pubmed: 19272829
Eur J Neurosci. 2015 Jul;42(1):1705-17
pubmed: 25943702
Appetite. 2015 Jan;84:204-11
pubmed: 25453591
Obesity (Silver Spring). 2008 May;16(5):945-50
pubmed: 18292747
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
Neurol Med Chir (Tokyo). 2003 Sep;43(9):457-60
pubmed: 14560852
Neuroimage. 2017 Sep;158:332-345
pubmed: 28711737
Neuroinformatics. 2014 Oct;12(4):575-93
pubmed: 24952892
Neuropsychol Rev. 2015 Dec;25(4):398-410
pubmed: 26577509
J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):56-62
pubmed: 21304139
Neuroimage. 2018 Apr 15;170:271-282
pubmed: 28536045
Neurologia. 2002 Jun-Jul;17(6):310-6
pubmed: 12084357
Neuroimage. 2018 Mar;168:403-411
pubmed: 27688203
Lancet Neurol. 2014 Mar;13(3):287-305
pubmed: 24556007
Mov Disord. 2005 Feb;20(2):172-80
pubmed: 15382210
Cortex. 2017 Jul;92:150-161
pubmed: 28494345
Case Rep Med. 2012;2012:768580
pubmed: 23125861
Neuroimage. 2020 Oct 1;219:117018
pubmed: 32505698
Neuroimage. 2003 Aug;19(4):1381-94
pubmed: 12948696
Neuroimage. 2004 Apr;21(4):1790-7
pubmed: 15050599
Regul Pept. 2008 Aug 7;149(1-3):3-10
pubmed: 18514925
Mov Disord. 2008 Dec 15;23(16):2377-83
pubmed: 18785648
Mov Disord. 2014 Dec;29(14):1781-7
pubmed: 25382049
Mov Disord. 2005 Aug;20(8):1052-5
pubmed: 15858803
Brain. 2007 Jul;130(Pt 7):1808-18
pubmed: 17535833
Mov Disord. 2012 Aug;27(9):1078-82
pubmed: 22700383
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):758-66
pubmed: 26296870
J Neurol Neurosurg Psychiatry. 2015 May;86(5):562-4
pubmed: 25012201
Mov Disord Clin Pract. 2018 Feb 28;5(3):246-254
pubmed: 30363375
Obes Rev. 2003 Nov;4(4):229-38
pubmed: 14649373
Ann Neurol. 2014 Aug;76(2):279-95
pubmed: 24953991
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
J Clin Neurosci. 2009 Sep;16(9):1148-52
pubmed: 19553125
Mov Disord. 2006 Jun;21 Suppl 14:S171-96
pubmed: 16810718
Behav Brain Res. 2009 Mar 2;198(1):149-58
pubmed: 19028527
Neuroimage. 2007 Aug 15;37(2):410-21
pubmed: 17566768
Front Neurol. 2014 Jun 02;5:84
pubmed: 24917848
Brain. 2008 Jun;131(Pt 6):1599-608
pubmed: 18490359
Trends Endocrinol Metab. 2008 Dec;19(10):362-70
pubmed: 18938086
J Neurosci. 2013 Mar 13;33(11):4804-14
pubmed: 23486951
Stroke. 1993 Nov;24(11):1625-30
pubmed: 8236333
Eur J Neurosci. 2009 Oct;30(8):1625-35
pubmed: 19811532
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Neurol Sci. 2011 Nov 15;310(1-2):267-70
pubmed: 21764406
Neuroimage. 2015 Feb 15;107:127-135
pubmed: 25498389
Neuroendocrinology. 2013;97(3):283-90
pubmed: 23051911
Hum Brain Mapp. 2014 Oct;35(10):5083-92
pubmed: 24777915
N Engl J Med. 2003 Nov 13;349(20):1925-34
pubmed: 14614167
Neuroimage. 2012 Mar;60(1):83-94
pubmed: 22173294

Auteurs

Katsuki Eguchi (K)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan. k198762@gmail.com.

Shinichi Shirai (S)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Masaaki Matsushima (M)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Takahiro Kano (T)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Kazuyoshi Yamazaki (K)

Department of Neurosurgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Shuji Hamauchi (S)

Department of Neurosurgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Toru Sasamori (T)

Department of Neurosurgery, Sapporo Azabu Neurosurgical Hospital, Kita 22, Higashi 1, Higashi-ku, 065-0022, Sapporo, Japan.

Toshitaka Seki (T)

Department of Neurosurgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Kenji Hirata (K)

Department of Diagnostic Imaging, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Mayumi Kitagawa (M)

Sapporo Teishinkai Hospital, Kita 33, Higashi 1, Higashi-ku, 065-0033, Sapporo, Japan.

Mika Otsuki (M)

Faculty of Health Sciences, Graduate School of Health Sciences, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Tohru Shiga (T)

Department of Nuclear Medicine, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Kiyohiro Houkin (K)

Department of Neurosurgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Hidenao Sasaki (H)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Ichiro Yabe (I)

Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH